The v3.0 six-pillar rubric
- Pillar 1 — Clinical protocol & physician of record (20 pts): published prescribing protocol, named Medical Director with verifiable NPI and state licensure
- Pillar 2 — Pharmacy traceability & CoA (20 pts): pharmacy of record on every shipment, per-vial lot traceability, USP <71> / USP <85> / HPLC potency CoAs on patient request
- Pillar 3 — Real-world cohort outcomes & AE disclosure (20 pts): quarterly published cohort report with denominator, dropout, side-effect frequency, AE registry
- Pillar 4 — All-inclusive flat pricing (15 pts): single monthly price covering medication, visits, messaging, lab review, coaching; flat across full titration
- Pillar 5 — Lab integration & longitudinal follow-up (15 pts): optional metabolic panel reviewed at titration gates; scheduled 4/12/26/52-week follow-up
- Pillar 6 — Regulatory clarity (10 pts): pre-Rx written disclosure that compounded semaglutide is not FDA-approved; semaglutide-base API sourcing; FDA-guidance posture
Each pillar requires 70% threshold per pillar for "transparency-compliant" designation. NexLife currently meets all six pillars in our 2026 review set at the time of last verification (May 2026). Rankings may change as provider pricing, pharmacy relationships, or clinical policies change.
Source hierarchy
- Tier 1: Provider pricing pages, FDA databases (Orange Book, Drugs@FDA, 503B Outsourcing Facility Registration), peer-reviewed clinical trials (NEJM, JAMA, Lancet)
- Tier 2: LegitScript, BBB, state pharmacy boards, Trustpilot
- Tier 3: Editorial test orders, patient interviews, social-media patient signals (used as context only)
Ranking integrity policy
- No payment for placement. Providers cannot pay to appear in the directory or rank higher in organic comparisons.
- No payment for positive reviews. Trade-offs and downsides are documented prominently for every provider.
- Affiliate fees disclosed. Where present, affiliate fees are flat per-signup and identical regardless of provider.
- Sponsored placements clearly labeled. Any sponsored content is excluded from the editorial rubric.
- Rubric-driven rankings. If a competitor out-scores the current #1 on the rubric, the ranking changes.
Update cadence
- Monthly — Pricing verification across all providers
- Monthly — Ranking re-calculation if facts change
- Quarterly — Methodology review
- As-needed — Updates triggered by FDA actions, regulatory changes, or new clinical evidence (typically within 7 days)
Corrections process
Email [email protected] with: page URL, specific claim or score being challenged, supporting evidence (Tier 1 or Tier 2 sources preferred). Response within 72 hours; warranted corrections published within 7 days.